Synergistic embryotoxicity of combination pyrimethamine and folic acid in rats.
The increased embryotoxicity of pyrimethamine (PYM) with concomitant oral dosing of folic acid (FA) was examined in rats. The preventive effects of folinic acid (FNA) on PYM embryotoxicity were also examined. Six groups were constructed: PYM I (PYM 1.2 mg/kg/day), FA (FA 50 mg/kg/day), PYM I+FA (1.2 and 50 mg/kg/day, respectively), PYM II (2.7 mg/kg/day), PYM II+FNA (2.7 and 12 mg/kg/day, respectively), and a vehicle control group. The agents were administered for 11 days from day 7 throughout 17 of gestation. PYM and FA were administered by gavage and FNA was administered intraperitoneally. Visceral and skeletal malformations were observed in the fetuses of both PYM I+FA and PYM II groups; these included dilatation of the lateral ventricle and fused ribs. No malformed fetuses were observed in the fetuses of the other four groups. External malformations were observed only in the fetuses of PYM II groups; these included cleft palate, cleft lips, and brachygnathia, among others. These results show that the concomitant gavage dosing of FA augments PYM embryotoxicity. The preventive effects of FNA were also confirmed.
Chung
M K
MK
Toxicology Research Center, Korea Research Institute of Chemical Technology, Daedeog-Danji, Daejeon.
Han
S S
SS
Roh
J K
JK
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D000818:Animals; D004357:Drug Synergism; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005492:Folic Acid / Q000008:administration & dosage / Q000633:toxicity*; D002955:Leucovorin / Q000494:pharmacology; D008297:Male; D011247:Pregnancy; D011739:Pyrimethamine / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley
D005492:Folic Acid; D002955:Leucovorin; D011739:Pyrimethamine